other material
confidence high
sentiment neutral
materiality 0.60
Prime Medicine reports preliminary cash of ~$135.2M as of Dec 31, 2023
Prime Medicine, Inc.
- Preliminary unaudited cash, equivalents, short-term investments, and restricted cash total ~$135.2M.
- Excluding $13.5M restricted cash, liquid assets are ~$121.7M.
- Company has not yet completed year-end close; final results may differ materially.
- Estimates are management-prepared and not audited; no assurance of final figures.